(Q34235318)

31 July 2017

1 reference

title

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials (English)

1 reference

31 July 2017

1 reference

1 reference

Aminimanizani A

1

1 reference

31 July 2017

Beringer P

series ordinal

2

1 reference

31 July 2017

Jelliffe R

series ordinal

3

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Clinical Pharmacokinetics

31 July 2017

published in

1 reference

31 July 2017

volume

40

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

169-187

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200140030-00003

31 July 2017

exact match

0 references

cites work

Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003088-200140030-00003

Absence of effect of rufloxacin on theophylline pharmacokinetics in steady state

21 January 2018

1 reference

12 December 2020

The effect of ferrous sulphate and sucralfate on the bioavailability of oral gemifloxacin in healthy volunteers.

1 reference

12 December 2020

Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers

1 reference

12 December 2020

Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery

1 reference

12 December 2020

Effect of Maalox on the bioavailability of oral gemifloxacin in healthy volunteers

1 reference

12 December 2020

Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid

1 reference

12 December 2020

Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review

1 reference

12 December 2020

Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections: a review of microbiologic and pharmacokinetic-pharmacodynamic characteristics

1 reference

12 December 2020

Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci

1 reference

12 December 2020

Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults.

1 reference

12 December 2020

A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses

1 reference

12 December 2020

Effect of Maalox on the oral absorption of sparfloxacin

1 reference

12 December 2020

Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of newer fluoroquinolones

1 reference

12 December 2020

Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species

1 reference

12 December 2020

Comparative pharmacokinetics of new quinolones.

1 reference

12 December 2020

Clinical pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers

1 reference

12 December 2020

Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review

1 reference

12 December 2020

Enantioselective disposition of ofloxacin in humans

1 reference

12 December 2020

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

1 reference

12 December 2020

Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium

1 reference

12 December 2020

Biliary excretion of rufloxacin in humans.

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

12 December 2020

Dose ranging study and constant infusion evaluation of ciprofloxacin

1 reference

12 December 2020

Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration

1 reference

12 December 2020

Levofloxacin, a second-generation fluoroquinolone.

1 reference

12 December 2020

Ciprofloxacin: multiple-dose pharmacokinetic and clinical results in patients with hypercrinic bronchopulmonary diseases

1 reference

12 December 2020

Pharmacokinetics of sparfloxacin in patients with renal impairment

1 reference

12 December 2020

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

1 reference

12 December 2020

The clinical pharmacokinetics of levofloxacin

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

1 reference

12 December 2020

The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin

1 reference

12 December 2020

Ciprofloxacin penetration into lungs

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora

1 reference

12 December 2020

Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with high-dose ciprofloxacin

1 reference

12 December 2020

Levofloxacin and sparfloxacin: new quinolone antibiotics

1 reference

12 December 2020

Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg

1 reference

12 December 2020

The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae

1 reference

12 December 2020

Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate

1 reference

12 December 2020

[Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections]

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast

1 reference

12 December 2020

Relationships between renal function and disposition of oral ciprofloxacin

1 reference

12 December 2020

Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone

1 reference

12 December 2020

Ciprofloxacin and antacids

1 reference

12 December 2020

Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin

1 reference

12 December 2020

Expanded activity and utility of the new fluoroquinolones: a review

1 reference

12 December 2020

The pharmacokinetics of ciprofloxacin in patients with impaired renal function

1 reference

12 December 2020

Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration

1 reference

12 December 2020

Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals

1 reference

12 December 2020

Quinolone antimicrobial agents and theophylline

1 reference

12 December 2020

Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis

1 reference

12 December 2020

Possible interaction between ciprofloxacin and warfarin

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

1 reference

12 December 2020

Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers

1 reference

12 December 2020

1 reference

12 December 2020

The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects

1 reference

12 December 2020

Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans

1 reference

12 December 2020

Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics and inflammatory fluid penetration of sparfloxacin

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics in burn patients.

1 reference

12 December 2020

Tissue penetration and metabolism of ciprofloxacin

1 reference

12 December 2020

Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers

1 reference

12 December 2020

Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection

1 reference

12 December 2020

Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects

1 reference

12 December 2020

Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of rufloxacin in patients with impaired renal function

1 reference

12 December 2020

Clinical pharmacokinetics of sparfloxacin

1 reference

12 December 2020

Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers

1 reference

12 December 2020

Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability

1 reference

12 December 2020

Pharmacokinetics of rufloxacin in healthy volunteers

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic surrogate markers: studies with fluoroquinolones in patients

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers

1 reference

12 December 2020

Penetration of moxifloxacin into peripheral compartments in humans.

1 reference

12 December 2020

Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding

1 reference

12 December 2020

Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function

1 reference

12 December 2020

Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers

1 reference

12 December 2020

Tissue penetration of ciprofloxacin after single and multiple doses

1 reference

12 December 2020

The penetration of rufloxacin into sites of potential infection in the respiratory tract.

1 reference

12 December 2020

Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters

1 reference

12 December 2020

Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients

1 reference

12 December 2020

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

1 reference

12 December 2020

10.2165/00003088-200140030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1052481449

0 references

1 reference